Suchergebnisse - "Clinical Trial, Phase III"

PubPharm (3.890)

1

Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system

enthalten in: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology | 2009

von Oliver, S. | Cloud, G. | Sánchez, P. | +10

2

Transarterial chemotherapy alone versus transarterial chemoembolization for hepatocellular carcinoma : a randomized phase III trial

enthalten in: Journal of hepatology | 2009

von Okusaka, T. | Kasugai, H. | Shioyama, Y. | +11

CommentIn: J Hepatol. 2009 Dec;51(6):981-3. - PMID 19853950

3

Trospium chloride extended release is effective and well tolerated in women with overactive bladder syndrome

enthalten in: International urogynecology journal and pelvic floor dysfunction | 2009

von Sand, P. | Dmochowski, R. | Zinner, N. | +2

4

Escitalopram is a weak inhibitor of the CYP2D6-catalyzed O-demethylation of (+)-tramadol but does not reduce the hypoalgesic effect in experimental pain

enthalten in: Clinical pharmacology and therapeutics | 2009

von Noehr-Jensen, L. | Zwisler, S. | Larsen, F. | +3

5

A randomized phase III prospective trial of bethanechol to prevent mucositis, candidiasis, and taste loss in patients with head and neck cancer undergoing radiotherapy : a secondary analysis

enthalten in: Journal of oral science | 2009

von Jham, B. | Chen, H. | Carvalho, A. | +1

6

Quantitative PCR analysis for Bcl-2/IgH in a phase III study of Yttrium-90 Ibritumomab Tiuxetan as consolidation of first remission in patients with follicular lymphoma

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2009

von Goff, L. | Summers, K. | Iqbal, S. | +8

7

VMP (Bortezomib, Melphalan, and Prednisone) is active and well tolerated in newly diagnosed patients with multiple myeloma with moderately impaired renal function, and results in reversal of renal impairment : cohort analysis of the phase III VISTA study

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2009

von Dimopoulos, M. | Richardson, P. | Schlag, R. | +15

8

Y-box-binding protein YB-1 identifies high-risk patients with primary breast cancer benefiting from rapidly cycled tandem high-dose adjuvant chemotherapy

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2009

von Gluz, O. | Mengele, K. | Schmitt, M. | +11

9

beta-Tubulin-II expression strongly predicts outcome in patients receiving induction chemotherapy for locally advanced squamous carcinoma of the head and neck : a companion analysis of the TAX 324 trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2009

von Cullen, K. | Schumaker, L. | Nikitakis, N. | +5

10

Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer : a phase 3, open-label, randomised controlled trial

enthalten in: Lancet (London, England) | 2009

von Albain, K. | Barlow, W. | Ravdin, P. | +18

CommentIn: Lancet. 2009 Dec 19;374(9707):2029-2030. - PMID 20004965

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[389]